via NewMediaWire –
Aemetis, Inc. (NASDAQ: AMTX), a
renewable natural gas and renewable fuels company focused on low
and negative carbon intensity products, today announced its
financial results for the fourth quarter and twelve months ended
December 31, 2023.
“Revenues were $70.8 million for the fourth quarter of 2023, an
increase from $66.7 million for the fourth quarter of 2022.
Revenues for the full year of 2023 were $186.7 million which
includes growth in revenue to $77.2 million from the India
Biodiesel segment and $5.5 million from the California
Renewable Natural Gas segment, along with the decrease in revenue
from the extended maintenance and upgrade cycle at the Keyes plant
which allowed for the acceleration of the implementation of several
important ethanol plant efficiency upgrades during the historically
high natural gas price period in early 2023,” said Todd Waltz,
Chief Financial Officer of Aemetis. “Capital expenditures for
carbon intensity reduction and production expansion projects were
$33 million for 2023 as our engineering and construction teams
moved forward with the initiatives outlined in our Five Year Plan,”
added Waltz.
During 2023, Aemetis achieved key milestones, including:
|
● |
Repaid $50.2 million of Third Eye
Capital debt in Q3 2023, reducing loan balances for the Aemetis
Biogas, Aemetis Keyes ethanol plant, Aemetis Riverbank SAF/RD, and
Aemetis CCS projects; |
|
● |
Adjusted EBITDA plus IRA
investment tax credit sales generated $32.7 million of
positive cash flow during 2023; |
|
● |
Received the key Use Permit and
CEQA last year and recently received the Authority to Construct air
permits to build a 90 million gallon per year sustainable aviation
fuel and renewable diesel plant at Riverbank Industrial
Complex; |
|
● |
Extended repayment on
$108 million of Third Eye Capital debt related to Aemetis
Biogas at an effective interest rate of 8.5% for the
first four months of 2024; |
|
● |
Received $55 million from the
sale of $63 million of IRA investment tax credits related to
qualified biogas project capital expenditures by Aemetis
Biogas; |
|
● |
Closed $50 million of new credit
facilities related to USDA guaranteed loans, including $25 million
of existing credit facilities and $25 million of additional 20-year
financing to fund capital expenditures at Aemetis Biogas; |
|
● |
Increased Aemetis Biogas
commissioned production capacity by 300% during 2023; |
|
● |
Commissioned 36 miles of biogas
pipeline, the biogas-to-RNG production facility, and the utility
gas interconnection unit; |
|
● |
Received approval of the CEQA
environmental review to extend the biogas pipeline to a total of 60
miles allowing for collection of biogas from an aggregate of about
40 dairies; |
|
● |
Received approval for the
generation of D3 RINs by our Renewable Natural Gas business and
completed the first sales of these D3 RINs; |
|
● |
Received the first CO2
sequestration characterization well permit issued by the State of
California to a private company; |
|
● |
Expanded our India biodiesel
production capacity to 60 million gallons per year ahead of
schedule; and |
|
● |
Received allocations for a
combined $184 million of biodiesel sales in India for 2023 and the
first three quarters of 2024, which we expect to continue as an
ongoing fuel supply relationship with the three government-owned
oil marketing companies in India. |
“In addition to achieving important operational milestones
during 2023 in all of our business segments, we closed one new
credit facility and refinanced another construction debt facility
for an aggregate of $50 million of USDA-guaranteed, 20-year funding
to construct dairy digesters,” said Eric McAfee, Chairman and CEO
of Aemetis. “We invite investors to review the updated Aemetis Five
Year Plan on the Aemetis home page prior to the earnings call.”
Today, Aemetis will host an earnings review call at 11:00 a.m.
Pacific time (PT).
Live Participant Dial In (Toll Free):
+1-888-506-0062 entry code 971618Live Participant Dial In
(International): +1-973-528-0011 entry code 971618Webcast URL:
https://www.webcaster4.com/Webcast/Page/2211/50051
For the presentation and details on the call,
please visit
http://www.aemetis.com/investors/conference-calls/.
Financial Results for the Three Months Ended December
31, 2023
Revenues were $70.8 million for the fourth quarter of 2023, an
increase from $66.7 million for the fourth quarter of 2022. The
ethanol gallons sold increased from 13.4 million gallons during the
fourth quarter of 2022 to 15 million gallons during the fourth
quarter of 2023. Biodiesel sales of 18.3 thousand metric tons were
recorded during the fourth quarter of 2023 at $1,157 per metric
ton. Our California Ethanol segment accounted for $45 million of
revenues and our India Biodiesel segment accounted for $22 million
of revenues during the period.
Cost of Goods Sold increased from $67.9 million during the
fourth quarter of 2022 to $69.9 million during the fourth
quarter of 2023, due to 18% increase in feedstock costs from the
incremental sales in our India Biodiesel segment coupled with an
increase in corn ground from 4.3 million bushels during the fourth
quarter of 2022 to 5.2 million bushels during the fourth quarter of
2023 offset by a 33% decrease in the average delivered cost of
corn.
Gross profit for the fourth quarter of 2023 was
$864 thousand, compared to a gross loss of $1.1 million during
the same period in 2022.
Selling, general and administrative expenses rose from $7.5
million during the fourth quarter of 2022 to $9.8 million during
the fourth quarter of 2023.
Operating loss was $9.0 million for the fourth quarter of 2023,
compared to an operating loss of $8.7 million during the fourth
quarter of 2022.
Net loss was $25.4 million for the fourth quarter of 2023,
compared to a net loss of $22.4 million for the fourth quarter of
2022.
Cash at the end of the fourth quarter of 2023 was $2.7 million,
compared to $4.3 million at the end of the fourth quarter of
2022.
Financial Results for the Twelve Months Ended December
31, 2023
Revenues were $187 million for the twelve months ended December
31, 2023, compared to $257 million for 2022. During
2023, $77.2 million revenues were generated by the India
Biodiesel segment and $5.5 million revenues were generated
by the California Renewable Natural Gas segment, and $104.3
million revenues were generated by the California ethanol
segment due to the extended maintenance cycle at the Keyes ethanol
plant which allowed for the acceleration of the implementation of
several important ethanol plant efficiency upgrades during the
historically high natural gas prices.
Cost of Goods Sold decreased from $262 million during the twelve
months ended December 31, 2022 to $185 million during the same
period in 2023 following the revenue changes during 2023. In
addition, delivered corn cost decreased from an average of $9.65
per bushel during the twelve months of 2022 to $7.11 per
bushel during the twelve months of 2023.
Gross profit for the twelve months ended December 31, 2023 was
$2.0 million, compared to a gross loss of $5.5 million during the
same period in 2022. Our India Biodiesel segment accounted for $9.0
million of gross profit from sales of biodiesel for the year ended
December 31, 2023.
Selling, general and administrative expenses increased to
$39.3 million during the twelve months ended December 31,
2023, compared to $28.7 million during the same period in 2022
primarily attributable to the stock compensation of $5.0 million
and the reclassification of expenses from cost of goods sold during
the extended maintenance cycle of the Keyes plant.
Operating loss was $37.4 million for the twelve months ended
December 31, 2023, compared to an operating loss of $34.4 million
for the same period in 2022, with the Keyes Plant only operating
for 7 months in 2023
Interest expense was $39.5 million during the year ended
December 31, 2023, excluding accretion and other expense of Series
A preferred units in our Aemetis Biogas LLC subsidiary, compared to
interest expense of $28.8 million during the year ended December
31, 2022. Additionally, our Aemetis Biogas LLC subsidiary
recognized $25.3 million of accretion and debt extinguishment costs
in connection with redemption liabilities on its preferred stock
during the year ended December 31, 2023, compared to $59.3 million
during the same period in 2022.
Net loss was $46.4 million for the twelve months ended
December 31, 2023, compared to a net loss of $107.8 million during
the same period in 2022.
Cash at the end of the fourth quarter of 2023 was $2.7 million
compared to $4.3 million at the end of the twelve months ended
December 31, 2022. Investments in our low carbon initiatives
increased property, plant and equipment by $33 million while debt
repayments of $51.3 million were made to our senior lender
during the twelve months ended December 31, 2023.
About Aemetis
Headquartered in Cupertino, California, Aemetis
is a renewable natural gas, renewable fuel and biochemicals company
focused on the acquisition, development and commercialization of
innovative technologies that replace petroleum-based products and
reduce greenhouse gas emissions. Founded in 2006, Aemetis is
operating and actively expanding a California biogas digester
network and pipeline system to convert dairy waste gas into
Renewable Natural Gas. Aemetis owns and operates a 65 million
gallon per year ethanol production facility in California’s Central
Valley near Modesto that supplies about 80 dairies with animal
feed. Aemetis owns and operates a 60 million gallon per year
production facility on the East Coast of India producing high
quality distilled biodiesel and refined glycerin for customers in
India and Europe. Aemetis is developing the sustainable aviation
fuel (SAF) and renewable diesel fuel biorefinery in California to
utilize renewable hydrogen, hydroelectric power, and renewable oils
to produce low carbon intensity renewable jet and diesel fuel. For
additional information about Aemetis, please visit
www.aemetis.com.
NON-GAAP FINANCIAL INFORMATION
We have provided non-GAAP measures as a
supplement to financial results based on GAAP. A reconciliation of
the non-GAAP measures to the most directly comparable GAAP measures
is included in the accompanying supplemental data. Adjusted EBITDA
is defined as net income/(loss) plus (to the extent deducted in
calculating such net income) interest expense, loss on debt
extinguishment, loss on lease termination, USDA cash grants, income
tax expense or benefit, intangible and other amortization expense,
accretion expense, depreciation expense, gain on litigation, loss
on impairment of intangibles and share-based compensation
expense.
Adjusted EBITDA is not calculated in accordance
with GAAP and should not be considered as an alternative to net
income/(loss), operating income or any other performance measures
derived in accordance with GAAP or to cash flows from operating,
investing or financing activities as an indicator of cash flows or
as a measure of liquidity. Adjusted EBITDA is presented solely as a
supplemental disclosure because management believes that it is a
useful performance measure that is widely used within the industry
in which we operate. In addition, management uses Adjusted EBITDA
for reviewing financial results, for budgeting and planning
purposes and as a non-GAAP liquidity measure. Adjusted EBITDA
measures are not calculated in the same manner by all companies
and, accordingly, may not be an appropriate measure for comparison
between companies.
Safe Harbor Statement
This news release contains forward-looking statements, including
statements regarding our assumptions, projections, expectations,
targets, intentions or beliefs about future events or other
statements that are not historical facts. Forward-looking
statements in this news release include, without limitation,
statements relating to our five-year growth plan; trends in market
conditions with respect to prices for inputs for our products
versus prices for our products; our ability to fund, develop,
build, maintain and operate digesters, facilities and pipelines for
our Dairy Renewable Natural Gas segment; our ability to fund,
develop and operate our Sustainable Aviation Fuel, Renewable
Diesel, and Carbon Capture and Sequestration projects, including
obtaining required permits; our ability to receive awarded grants
by meeting all of the required conditions, including meeting the
minimum contributions; our ability to fund, develop and operate our
sustainable aviation fuel and renewable biodiesel projects; our
intention to repurchase the Series A preferred units relating to
our Aemetis Biogas subsidiary and the expected valuation premium
thereof; and our ability to raise additional capital. Words or
phrases such as “anticipates,” “may,” “will,” “should,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,”
“showing signs,” “targets,” “view,” “will likely result,” “will
continue” or similar expressions are intended to identify
forward-looking statements. These forward-looking statements are
based on current assumptions and predictions and are subject to
numerous risks and uncertainties. Actual results or events could
differ materially from those set forth or implied by such
forward-looking statements and related assumptions due to certain
factors, including, without limitation, competition in the ethanol,
biodiesel and other industries in which we operate, commodity
market risks including those that may result from current weather
conditions, financial market risks, customer adoption,
counter-party risks, risks associated with changes to federal
policy or regulation, and other risks detailed in our reports filed
with the Securities and Exchange Commission, including Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, and other
filed documents. We are not obligated, and do not intend, to update
any of these forward-looking statements at any time unless an
update is required by applicable securities laws.
External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com
Company Contact:
Todd Waltz
Chief Financial Officer
(408) 213-0925
twaltz@aemetis.com
(Tables follow)
AEMETIS,
INC.CONSOLIDATED CONDENSED STATEMENTS OF
OPERATIONS(In thousands, except per share
data)
|
|
For the three months ended December 31, |
|
|
For the years ended December 31, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Revenues |
|
$ |
70,764 |
|
|
$ |
66,732 |
|
|
$ |
186,717 |
|
|
$ |
256,513 |
|
Cost of goods sold |
|
|
69,900 |
|
|
|
67,864 |
|
|
|
184,700 |
|
|
|
262,048 |
|
Gross profit (loss) |
|
|
864 |
|
|
|
(1,132 |
) |
|
|
2,017 |
|
|
|
(5,535 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
expenses |
|
|
37 |
|
|
|
41 |
|
|
|
152 |
|
|
|
180 |
|
Selling, general and
administrative expenses |
|
|
9,786 |
|
|
|
7,520 |
|
|
|
39,266 |
|
|
|
28,686 |
|
Operating loss |
|
|
(8,959 |
) |
|
|
(8,693 |
) |
|
|
(37,401 |
) |
|
|
(34,401 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense (income): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate expense |
|
|
8,869 |
|
|
|
6,588 |
|
|
|
32,995 |
|
|
|
21,407 |
|
Debt related fees and amortization expense |
|
|
1,792 |
|
|
|
2,164 |
|
|
|
6,524 |
|
|
|
7,363 |
|
Accretion and other expenses of Series A preferred units |
|
|
5,125 |
|
|
|
3,968 |
|
|
|
25,313 |
|
|
|
9,888 |
|
Loss on debt extinguishment |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
49,386 |
|
Other income |
|
|
(57 |
) |
|
|
(43 |
) |
|
|
(2,077 |
) |
|
|
(15,740 |
) |
Loss before income taxes |
|
|
(24,688 |
) |
|
|
(21,370 |
) |
|
|
(100,156 |
) |
|
|
(106,705 |
) |
Income tax expense (benefit) |
|
|
754 |
|
|
|
1,040 |
|
|
|
(53,736 |
) |
|
|
1,053 |
|
Net loss |
|
$ |
(25,442 |
) |
|
$ |
(22,410 |
) |
|
$ |
(46,420 |
) |
|
$ |
(107,758 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.64 |
) |
|
$ |
(0.63 |
) |
|
$ |
(1.22 |
) |
|
$ |
(3.12 |
) |
Diluted |
|
$ |
(0.64 |
) |
|
$ |
(0.63 |
) |
|
$ |
(1.22 |
) |
|
$ |
(3.12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
39,674 |
|
|
|
35,302 |
|
|
|
38,061 |
|
|
|
34,585 |
|
Diluted |
|
|
39,674 |
|
|
|
35,302 |
|
|
|
38,061 |
|
|
|
34,585 |
|
AEMETIS,
INC.CONSOLIDATED CONDENSED BALANCE
SHEETS(In thousands)
|
|
As ofDecember 31, |
|
|
|
2023 |
|
|
2022 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,667 |
|
|
$ |
4,313 |
|
Accounts receivable |
|
|
8,633 |
|
|
|
1,264 |
|
Inventories |
|
|
18,291 |
|
|
|
4,658 |
|
Prepaid and other current assets |
|
|
6,809 |
|
|
|
7,901 |
|
Total current assets |
|
|
36,400 |
|
|
|
18,136 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
195,108 |
|
|
|
180,441 |
|
Other assets |
|
|
11,898 |
|
|
|
8,537 |
|
Total assets |
|
$ |
243,406 |
|
|
$ |
207,114 |
|
|
|
|
|
|
|
|
|
|
Liabilities and
stockholders' deficit |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
32,132 |
|
|
$ |
26,168 |
|
Current portion of long term debt |
|
|
13,585 |
|
|
|
12,465 |
|
Short term borrowings |
|
|
23,443 |
|
|
|
36,754 |
|
Mandatorily redeemable Series B convertible preferred stock |
|
|
4,521 |
|
|
|
4,082 |
|
Other current liabilities |
|
|
10,708 |
|
|
|
8,812 |
|
Total current liabilities |
|
|
84,389 |
|
|
|
88,281 |
|
|
|
|
|
|
|
|
|
|
Total long term liabilities |
|
|
375,994 |
|
|
|
320,687 |
|
|
|
|
|
|
|
|
|
|
Stockholders' deficit: |
|
|
|
|
|
|
|
|
Series B convertible preferred stock |
|
|
- |
|
|
|
1 |
|
Common stock |
|
|
41 |
|
|
|
36 |
|
Additional paid-in capital |
|
|
264,058 |
|
|
|
232,546 |
|
Accumulated deficit |
|
|
(475,405 |
) |
|
|
(428,985 |
) |
Accumulated other comprehensive loss |
|
|
(5,671 |
) |
|
|
(5,452 |
) |
Total stockholders' deficit |
|
|
(216,977 |
) |
|
|
(201,854 |
) |
Total liabilities and
stockholders' deficit |
|
$ |
243,406 |
|
|
$ |
207,114 |
|
RECONCILIATION OF ADJUSTED EBITDA TO NET
INCOME / (LOSS) (In thousands,
unaudited)
|
|
For the three months ended December 31, |
|
|
For the years ended December 31, |
|
EBITDA Calculation |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
(25,442 |
) |
|
|
(22,410 |
) |
|
|
(46,420 |
) |
|
|
(107,758 |
) |
Adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
10,661 |
|
|
|
8,752 |
|
|
|
39,519 |
|
|
|
28,770 |
|
Depreciation expense |
|
|
1,725 |
|
|
|
1,496 |
|
|
|
6,933 |
|
|
|
5,535 |
|
Accretion of Series A preferred units |
|
|
5,125 |
|
|
|
3,968 |
|
|
|
25,313 |
|
|
|
9,888 |
|
Share-based compensation |
|
|
1,437 |
|
|
|
1,476 |
|
|
|
7,660 |
|
|
|
6,410 |
|
Intangibles and other |
|
|
36 |
|
|
|
12 |
|
|
|
72 |
|
|
|
46 |
|
Loss on debt extinguishment |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
49,386 |
|
Loss on lease termination |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
736 |
|
USDA cash grants |
|
|
- |
|
|
|
- |
|
|
|
(1,774 |
) |
|
|
(14,100 |
) |
Gain on litigation |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,400 |
) |
Income tax expense (benefit) |
|
|
754 |
|
|
|
1,040 |
|
|
|
(53,736 |
) |
|
|
1,053 |
|
Total adjustments |
|
|
19,738 |
|
|
|
16,744 |
|
|
|
23,987 |
|
|
|
86,324 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
(5,704 |
) |
|
|
(5,666 |
) |
|
|
(22,433 |
) |
|
|
(21,434 |
) |
PRODUCTION AND PRICE
PERFORMANCE(unaudited)
|
|
Three Months ended December 31, |
|
|
Years ended December 31, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Ethanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gallons sold (in millions) |
|
|
15.0 |
|
|
|
13.4 |
|
|
|
32.1 |
|
|
|
59.0 |
|
Average sales price/gallon |
|
$ |
2.20 |
|
|
$ |
2.65 |
|
|
$ |
2.44 |
|
|
$ |
2.81 |
|
Percent of nameplate capacity |
|
|
109 |
% |
|
|
98 |
% |
|
|
58 |
% |
|
|
107 |
% |
WDG |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tons sold (in thousands) |
|
|
102.6 |
|
|
|
90.0 |
|
|
|
225.3 |
|
|
|
396.9 |
|
Average sales price/ton |
|
$ |
97 |
|
|
$ |
125 |
|
|
$ |
97 |
|
|
$ |
128 |
|
Delivered Cost of
Corn |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bushels ground (in millions) |
|
|
5.2 |
|
|
|
4.3 |
|
|
|
11.5 |
|
|
|
20.2 |
|
Average delivered cost / bushel |
|
$ |
6.70 |
|
|
$ |
10.05 |
|
|
$ |
7.11 |
|
|
$ |
9.65 |
|
Dairy Renewable
Natural Gas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MMBtu external sales (in thousands) |
|
|
52.2 |
|
|
|
8.4 |
|
|
|
194.2 |
|
|
|
8.4 |
|
MMBtu stored as inventory (in thousands) |
|
|
68.0 |
|
|
|
9.0 |
|
|
|
68.0 |
|
|
|
9.0 |
|
MMBtu intercompany sales (in thousands) |
|
|
- |
|
|
|
4.4 |
|
|
|
- |
|
|
|
48.6 |
|
Biodiesel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metric tons sold (in thousands) |
|
|
18.3 |
|
|
|
10.7 |
|
|
|
60.5 |
|
|
|
17.7 |
|
Average Sales Price/Metric ton |
|
$ |
1,157 |
|
|
$ |
1,511 |
|
|
$ |
1,232 |
|
|
$ |
1,526 |
|
Percent of Nameplate Capacity |
|
|
49 |
% |
|
|
29 |
% |
|
|
40 |
% |
|
|
12 |
% |
Refined
Glycerin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metric tons sold (in thousands) |
|
|
1.3 |
|
|
|
1.2 |
|
|
|
4.2 |
|
|
|
1.2 |
|
Average Sales Price/Metric ton |
|
$ |
616 |
|
|
$ |
845 |
|
|
$ |
640 |
|
|
$ |
850 |
|
Grafico Azioni Aemetis (NASDAQ:AMTX)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Aemetis (NASDAQ:AMTX)
Storico
Da Nov 2023 a Nov 2024